NetworkNewsBreaks – Energy Fuels Inc. (NYSE Amer
Post# of 388
(Total Views: 311)
Posted On: 09/20/2021 3:37:54 PM
NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Enters Entirely New Realm – the World of Medicine
Energy Fuels (NYSE American: UUUU) (TSX: EFR) recently entered into a strategic alliance with RadTran LLC, a technology development company focused on closing critical gaps in the procurement of medical isotopes, to evaluate the recovery of thorium and possibly radium from the company’s existing rare earth carbonate and uranium process streams. “The company just began producing rare earths by unlocking the value of a mineral called monazite because this mineral contains the radioactive elements uranium and thorium. And UUUU’s most recent strategic partnership takes the company into an entirely new realm: the world of medicine,” reads a recent article. RadTran and UUUU “will work together to evaluate the potential to use thorium from existing rare earth and uranium process streams for the production of medical isotopes needed for emerging targeted alpha therapy (‘TAT’) cancer therapeutics.” With the limited supply of these isotopes constraining the research and development of new TAT drugs, Energy Fuels and the feeds at its White Mesa Mill “may offer a possible solution to this medical supply dilemma.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Energy Fuels (NYSE American: UUUU) (TSX: EFR) recently entered into a strategic alliance with RadTran LLC, a technology development company focused on closing critical gaps in the procurement of medical isotopes, to evaluate the recovery of thorium and possibly radium from the company’s existing rare earth carbonate and uranium process streams. “The company just began producing rare earths by unlocking the value of a mineral called monazite because this mineral contains the radioactive elements uranium and thorium. And UUUU’s most recent strategic partnership takes the company into an entirely new realm: the world of medicine,” reads a recent article. RadTran and UUUU “will work together to evaluate the potential to use thorium from existing rare earth and uranium process streams for the production of medical isotopes needed for emerging targeted alpha therapy (‘TAT’) cancer therapeutics.” With the limited supply of these isotopes constraining the research and development of new TAT drugs, Energy Fuels and the feeds at its White Mesa Mill “may offer a possible solution to this medical supply dilemma.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)